The difference in buoyant density between viral and normal polyribosomes in krebs II cells  by Zaslavsky, V.G. et al.
Volume 17, number 2 FEBS LETTERS October 1971 
THE DIFFERENCE IN BUOYANT DENSITY BETWEEN 
VIRAL AND NORMAL POLY RIBOSOMES IN KREBS II CELLS 
V.G. ZASLAVSKY, N.V. KAVERIN, Yu.A. SMIRNOV and N.V. SYURINA 
D.I. Ivanovsky Institute of Virology. Academy of Medical Sciences, Moscow, USSR 
Received 7 July 1971 
Original figures received 21 July 1971 
1. Introduction 
Viral polyribosomes in picornavirus-infected cells 
were shown to be larger in size than the polyribo- 
somes in uninfected cells [ 1,2] . If the only struc- 
tural difference between the two types of polyribo- 
somes is their size one should expect their buoyant 
density values to be identical. In this paper evidence 
of a small but definite difference in the buoyant den- 
sity of normal and viral polyribosomes is presented. 
2. Materials and methods 
Mouse ascites carcinoma Krebs II cells were washed, 
suspended in Earle’s saline at a concentration 5-19 X 
IO6 per 1 ml, inoculated with encephalomyocarditis 
(EMC) virus at a multiplicity lo-20 PFU per cell 
and incubated at 2-4” for 14- 16 hr. Actinomycin 
D was added (5 &ml), the suspension was heated 
up to 37” (this moment was considered to be the 
start of infection) and incubated at this temperature 
on a magnetic stirrer at low speed of rotation. The 
cells were labeled either with 3H-uridine (3 @/ml, 
0.3 Ci/mmole) from 2 to 5.5 hr post infection or 
during 2 min (5.5 hr post infection) with “C-chlor- 
ella hydrolysate (1 &i/ml). In some experiments 
the mixture of 3H-alanine (40 mCi/mmole) and 
3H-leucine (32 mCi/mmole) was used (0.5 &i/ml 
each). At the end of incubation the suspension was 
poured into frozen and crushed Earle’s saline. All 
subsequent procedures were performed at O-2”. 
The cells were pelleted, resuspended in standard 
North-Holland Publishing Company - Amsterdam 
buffer (0.01 M triethanolamine-HCI pH 7.8; 0.01 M 
KCl; 0.003 M Mg acetate) and destroyed in a tight- 
fitting Dounce homogenizer. The supernatant after 
the centrifugation at 15,000 g for 20 min (cytoplas- 
mic extract) was used for further analysis. Some 
portions of the extract were incubated for IO min 
at 0” with pancreatic ribonuclease (RNase) (5 ,ug/ml) 
or with sodium ethylenediaminetetraacetate (EDTA) 
(0.02 M, pH 7.6. The extracts were layered on 
15-30% (w/w) sucrose gradients containing 4% for- 
maldehyde [3], the top of the gradient being 1 ml 
of 5% sucrose without formaldehyde. All sucrose 
solutions were made in standard buffer or, for EDTA- 
treated material, in standard buffer lacking Mg2+. 
The gradients were centrifuged in a 3 X 23 rotor of 
a Superspeed- ultracentrifuge (MSE, England) at 
25,000 rpm and 2” for 90 min. Eighteen to twenty 
fractions were collected from each tube. Distilled 
water, 2.5 ml, was added to 0.1 ml aliquots from 
every fraction. A,, was measured in a spectrophoto- 
meter, SP4A (USSR). Acid-insoluble material was 
precipitated with trichloroacetic acid (TCA) in the 
presence of 0.2 mg of casein, washed on nitrocellulose 
filters (mean pore size 0.7 pm) with TCA and ethanol, 
immersed into scintillation fluid (PPO 5 g, POPOP 
0.3 g, toluene 1 1) and counted in Tricarb liquid 
scintillation spectrometer (Packard, USA). Chosen 
fractions from sucrose gradients were dialysed over- 
night against standard buffer containing 4% formal- 
dehyde and analysed in preformed CsCl gradients 
[4] (rotor 3 X 5, 35,000 rpm, 4-6”, 16-18 hr). In 
some experiments differently labeled materials were 
mixed after dialysis so as to ensure 2-5 times excess 
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Fig. 1. Analysis of viral RNA-containing structures. Cytoplas- 
mic extracts were analysed in sucrose gradients ;A, no treat- 
ment; B, RNase treatment; C, EDTA treatment; D, fraction 
14 from C was analysed in a CsCl gradient. 
of 3H-label over r4C (in cpm). After centrifugation 
the bottom of the tube was punctured and 23-25 
fractions were collected. Four drops from every 5th 
fraction were taken separately for refractometric 
measurement. The density of CsCl solution was de- 
termined from refractometric index [S] with a 
J 
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Fig. 2. The buoyant density (in CsCl) of virus-specific preri- 
bosomal structures (A) and free ribosomes (B) from deoxy- 
cholate-treated cytoplasmic extracts. The cytoplasmic ex- 
tracts were treated with DOC in final concentration 0.5%. 
correction for formaldehyde. AzbO and radioactivity 
were determined as described above. When r4C- and 
3H-labels were determined in the same sample the 
discrimination conditions were adjusted so less than 
1% of 3H-label was counted in the channel for 14C 
and no more than 10% of r4C-label were counted 
in the channel for 3H. Reagents: actinomycin D 
(Reanal, Hungary). RNase (Calbiochem, USA). EDTA 
(Sigma, USA). Labeled precursors of RNA and pro- 
tein (Isotop, USSR). 
3. Results and discussion 
3.1. The identification of vim1 polyribosomes and the 
determination of their buoyant density in CsCl. 
In actinomycin D-treated uninfected Krebs II cells 
RNA synthesis was decreased by 96-98%, and in cy- 
toplasmic extracts the amount of 3H-uridine-labeled 
acid-insoluble material was negligible. For this rea- 
son the labeled RNA in the extracts of EMC-virus- 
infected cells was considered to be virus-specific. 
This RNA was distributed in a wide preribosomal 
zone after a fractionation of the cytoplasmic extract 
in a sucrose gradient (fig. 1 A). Generally viral RNA- 
containing structures may include virions, viral poly- 
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Fig. 3. Sedimentation analysis of cytoplasmic extracts after pulse-labeling of infected cells with 14C-chlorella hydrolysate. A, no 
treatment; B, EDTA treatment; C, RNase treatment. 
ribosomes, replicative complexes, etc. The data pre- 
sented below indicate that the labeled preribosomal 
structures in EMC-virus infected Krebs II cells are 
represented mainly by viral polyribosomes. 
The treatment of cytoplasmic extract with RNase 
leads to a considerable general loss of radioactivity 
and to a removal of the labeled material from the 
preribosomal zone (fig. 1 B). This means that the 
preribosomal structures are not mature &ions. 
EDTA treatment leads to a displacement of the 
label to the 90-100 S zone (fig. 1C). A similar re- 
sult had been obtained with poliovirus polyribosomes 
[6] ; it had been shown that the 90 S component re- 
leased from polyribosomes is a ribonucleoprotein. 
For this reason the material of the 90- 100 S zone 
(fraction 14, fig. 1C) was analysed in a CsCl gradient. 
As can be seen from fig. 1D this material has a buoy- 
ant density of 1.44 g/ml which agrees well with simi- 
lar data on the component released from poliovirus 
polyribosomes [6]. 
So viral RNA-containing structures resemble poly- 
ribosomes in their sedimentation behaviour and in 
their sensitivity to RNase and EDTA. Their buoyant 
density in CsCl after dedxycholate (DOC) treatment 
of the extracts is 1.57-l .58 g/ml (fig. 2A) which is 
characteristic of polyribosomes [7] and identical 
with the density of DOC-treated free ribosomes (fig. 2B). 
To confirm the polyribosomal nature of viral RNA- 
containing preribosomal structures they were com- 
pared in buoyant density analysis with polyribosomes 
containing labeled nascent polypeptides. 
EMC-virus-infected Krebs II cells were labeled for 
2 min with r4C-chlorella hydrolysate. The label in 
the preribosomal zone after such pulse-labeling is 
assumed to belong to nascent polypeptides [8]. The 
analysis of the extracts of pulse-labeled Krebs II cells 
has shown that radioactivity of the preribosomal 
zone (fig. 3A) may be displaced to the postribosomal 
zone after EDTA treatment (fig. 3B) and to the 
80 S zone after RNase treatment (fig. 3C). This in- 
dicates that the structures containing labeled proteins 
are polyribosomes. When they were fractionated in 
a CsCl gradient together with viral RNA-containing 
structures the buoyant densities of both types of 
structures were shown to be identical (fig. 4A). It 
should be noted that the density of free ribosomes 
(80 S W-absorbing material) is higher (fig. 4B). This 
is in agreement with the data obtained in other sys- 
tems [9]. 
Two conclusions may be drawn from this part of 
our data: (1) Preribosomal structures containing 
viral RNA are represented predominantly by viral 
polyribosomes; (2) The buoyant density of polyribo- 
somal material differs from that of 80 S ribosomes. 
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Fig. 4. The buoyant density of polyribosomal structures and 
of free ribosomes. EMC-virus-infected cells were incubated 
either with 3H-uridine or with “C-chlorella hydrolysate, A, 
3H- and r4C-preribosomal material mixed before fractiona- 
tion in a C.&l gradient; B, 80 S ribosomes. 
3.2. The buoyant density of viral and normal poly- 
n’bosomes and the action of RNase 
The buoyant density of viral polyribosomes in 
CsCl in several determinations had a value of 1.49- 
1.50 g/ml, while that of normal polyribosomes (i.e. 
polyribosomes from the extracts of uninfected cells 
pulse labeled with l4 C-chlorella hydrolysate) was 
usually 1.5 l-l .52 g/ml. In order to compare direct- 
ly the buoyant density of the two types of structures 
they were mixed and analysed together in the same 
gradient. The data presented in fig. 5A show that 
the buoyant density of viral polyribosomes is slight- 
ly ‘lower than that of polyribosomes from uninfect- 
ed cells. 
It had been supposed [6,10, 1 l] that mRNA in 
polyribosomes is associated with protein and that 
the lower density of polyribosomes as compared to 
monosomes is caused, at least in part, by this com- 
plex (mRNP) [9]. From this point of view the dif- 
ferent buoyant densities of viral and normal poly- 
ribosomes may be a consequence of a different 
spacing of ribosomes along mRNP strand and of a 
greater amount of mRNP per ribosome in the viral 
polyribosome as compared to the normal one. If 
this is so one could expect that RNase digestion of 
free parts of mRNP would lead to the disappearance 
of the difference in the buoyant densities of the two 
types of polyribosomes. 
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Fig. 5. A comparative buoyant density analysis of viral and 
normal polyribosomes and the effect of RNase on the buoy- 
ant density of both types of polyribosomes. EMC-virus-in- 
fected cells were incubated with either 3H-uridine or labeled 
protein precursors (3H-aminoacids or 14C-chlorella hrvdro- 
lysate). Uninfected cells were incubated with 3H- or 4C- 
protein precursors. RNasetreated and untreated extracts 
were fractionated in sucrose gradients. 3H- and r4C-labeled 
materials were mixed and analysed in CsCl gradients. A, 
polyribosomal material containing 3H-labeled viral RNA 
was mixed with polyribosomal material from uninfected cells 
containing 14C-labeled nascent proteins; B, polyribosomal 
material from infected cells containing 3H-labeled nascent 
proteins was mixed with 80 S material from RNase-treated 
extract of infected cells containing 14C-labeled nascent pro- 
teins; C 
. if 
olyribosomal material from uninfected cells con- 
taining C-labeled nascent proteins was mixed with 80 S 
material from RNase-treated extract of uninfected cells con- 
taining 3H-labeled nascent proteins; D, 80 S material from 
RNase treated extracts containing~3H-labeled nascent pro- 
teins (infected cells) and 14C-labeled nascent proteins (unin- 
fected cells). 
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The treatment of cytoplasmic extract with RNase 
leads to a displacement of the label (associated with 
nascent proteins) to the 80 S zone (fig. 3C). The 
buoyant density of the labeled material after such 
treatment increased if EMC-virus-infected cells were 
used (fig. 5B). No substantial increase in buoyant 
density was registered when RNase treatment was 
applied to extracts of uninfected cells (fig. 5C). When 
the 80 S materials from uninfected and infected cells 
(after RNase treatment of the extracts) were mixed 
and analysed in the same gradient no differences in 
the buoyant densities of the labeled structures could 
be detected (fig. 5D). It should be noted that RNase 
treatment slightly lowers the buoyant density of free 
80 S ribosomes (perhaps because of partial loss of 
ribosomal RNA). 
Three conclusions were drawn from this group of 
data: (1) The buoyant density of viral polyribosomes 
in EMC-virus-infected cells is lower than that of nor- 
mal polyribosomes; (2) RNase treatment affects the 
buoyant density of the viral polyribosomes much 
more strongly than that of the normal polyribosomes; 
(3) The difference in the buoyant densities between 
the two types of polyribosomes is abolished by RNase 
treatment. 
The basic experimental result of this work is the 
fact of lower buoyant density of viral polyribosomes 
in EMC-virus-infected cells as compared to normal 
polyribosomes. One of possible explanations of the 
fact may lie in the assumption of a different spacing 
of ribosomes along mRNP strand (in general terms, in 
a different amount of mRNP per ribosome). The data 
on the effect of RNase treatment upon the buoyant 
density of viral and normal polyribosomes are in 
agreement with this assumption. Some additional 
data cornforming to this suggestion are presented in 
another report [ 121. 
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